GU Cancer Research Program @HuntsmanCancer
@Huntsman_GU
Followers
762
Following
1K
Media
47
Statuses
881
Patient-focused care and research, clinical trials in #Genitourinary cancers #GU #Prostate #Kidney #Bladder #GermCell. @HuntsmanCancer @UUtah
Joined November 2020
RT @ASCO: 🎙 @neerajaiims of @huntsmancancer and Dr. Jeanny Aragon-Ching of @InovaSchar highlight key innovations in GU cancer research from….
0
19
0
RT @EAntonarakis: A novel west-African germline founder mutation in HOXB13 (p.X285Kext) increases risk of high-grade prostate cancer but al….
0
21
0
RT @chadihcmd: Excited to see our work published in @CCR_AACR ! Real-world pts w/ mHSPC #prostatecancer w/ HRRalt had worse survival than t….
0
23
0
RT @neerajaiims: Just in @CCR_AACR 👉Congrats @chadihcmd @umangtalking & @Huntsman_GU team👉Poor outcomes w/ SOC Rx in mHSPC #prostatecancer ….
0
46
0
RT @JCO_ASCO: Earlier today our journal editors shared lots of valuable info on “Publication 101: Peer Review & Becoming a Successful Autho….
0
3
0
RT @neerajaiims: Stellar presentation @ASCO #ASCO25 by trailblazer @DrRanaMcKay on ETCTN trial with radium +|- olaparib in mCRPC #prostatec….
0
22
0
RT @shilpaonc: #ASCO2025 Powerful letter from @ASCO #DailyNews Editor @neerajaiims .“In the fight against cancer, we are united by purpose.….
0
23
0
RT @DrChoueiri: We invite you to @ASCO @IMG_Oncologists today 4-6pm at #ASCO25 McCormick Place. ROOM S103 . @ZiadBakouny @NazliDizman https….
0
16
0
RT @ASCO: This week we went to DC with ASCO member @montypal for the #ASCOAdvocacySummit. Follow his day as he met with fellow ASCO advocat….
0
7
0
RT @FaltasLab: 🧩 ctDNA is a key piece of the puzzle in building an integrated precision oncology ecosystem at @WeillCornell. Excited to sha….
0
32
0
RT @urotoday: Examining post-prostatectomy metastasis patterns in hormone-sensitive #ProstateCancer. @nsayeghmd sits down with @neerajaiims….
0
10
0
RT @neerajaiims: Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCR….
0
36
0
RT @ziremozay: Just in @JAMANetworkOpen👉@flatironhealth Real world Rx data from >8500 pts w/ mRCC #kidneycancer 👉After 2018, only 38% & 14%….
0
42
0
RT @montypal: "On the Edge of Breakthrough: Voices of Cancer Research" premiered in the top 5% of podcasts! Thank you for your support! . F….
0
14
0
RT @montypal: Highly encourage everyone to peruse this terrific review in @EUplatinum from the stellar team of @neerajaiims @huntsmancancer….
0
11
0
RT @neerajaiims: Just in @EUplatinum 👉Overview of T-cell engagers (TCEs) in #prostatecancer👉promising anti-tumor activity, but challenges….
0
33
0
RT @CParkMD: ⭐️ Top 10 #GU25 Influencers so far at ASCO GU. @ASCO @neerajaiims @OncoAlert @DrChoueiri @crisbergerot @montypal @tompowles1 @….
0
17
0
RT @neerajaiims: Congrats to @DrChoueiri @motzermd for developing one of the most effective combinations cabozantinib + nivolumab for mRCC….
0
23
0
RT @neerajaiims: Outstanding talk and discussion on emerging treatment landscape of mRCC #kidneycancer by @TiansterZhang 👉 emphasizes the n….
0
22
0